Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
The global market for Recombinant Human Serum Albumin is estimated to increase from US$ 68 million in 2021 to reach US$ 113.3 million by 2028, exhibiting a CAGR of 7.6% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Global key players of recombinant human serum albumin include Albumedix, Merck, Ventria (InVitria), etc. The top three players hold a share about 88%. North America is the largest producer, holds a share around 46%, followed by Europe and China, with share 42% and 7%, separately. The largest market is North America, has a share about 59%, followed by Europe and China, with around 29% and 6% market share respectively.
Report Coverage
This latest report provides a deep insight into the global Recombinant Human Serum Albumin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Recombinant Human Serum Albumin market, with both quantitative and qualitative data, to help readers understand how the Recombinant Human Serum Albumin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Recombinant Human Serum Albumin market and forecasts the market size by Type (OsrHSA and ScrHSA,), by Application (Cell Culture Media, Medical Supplements and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
OsrHSA
ScrHSA
Segmentation by application
Cell Culture Media
Medical Supplements
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Chapter Introduction
Chapter 1: Scope of Recombinant Human Serum Albumin, Research Methodology, etc.
Chapter 2: Executive Summary, global Recombinant Human Serum Albumin market size (sales and revenue) and CAGR, Recombinant Human Serum Albumin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Recombinant Human Serum Albumin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Recombinant Human Serum Albumin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Recombinant Human Serum Albumin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen and HiMedia, etc.
Chapter 14: Research Findings and Conclusion